Vivo Capital VIII, LLC - Nov 21, 2023 Form 4 Insider Report for Bolt Biotherapeutics, Inc. (BOLT)

Role
10%+ Owner
Signature
Vivo Capital VIII, LLC, By: /s/ Frank Kung, Managing Member
Stock symbol
BOLT
Transactions as of
Nov 21, 2023
Transactions value $
-$3,060
Form type
4
Date filed
11/22/2023, 06:51 PM
Previous filing
Nov 20, 2023
Next filing
Dec 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BOLT Common Stock Sale -$1.54K -1.71K -0.09% $0.90 1.95M Nov 21, 2023 By: Vivo Capital Fund VIII, L.P. F1, F4
transaction BOLT Common Stock Sale -$212 -236 -0.09% $0.90 270K Nov 21, 2023 By: Vivo Capital Surplus Fund VIII, L.P. F2, F4
transaction BOLT Common Stock Sale -$1.31K -1.46K -1.29% $0.90 112K Nov 21, 2023 By: Vivo Opportunity Fund Holdings, L.P. F3, F4
holding BOLT Common Stock 1.45M Nov 21, 2023 By: Vivo Panda Fund, L.P.
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Vivo Capital VIII, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The shares are held of record by Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC is the General Partner of Vivo Capital Fund VIII, L.P. Vivo Capital VIII, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
F2 The shares are held of record by Vivo Capital Surplus Fund VIII, L.P. Capital VIII, LLC is the General Partner of Vivo Capital Surplus Fund VIII, L.P. Vivo Capital VIII, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
F3 The shares are held of record by Vivo Opportunity Fund Holdings, L.P. Vivo Opportunity, LLC is the General Partner of Vivo Opportunity Holdings, L.P. Vivo Opportunity, LLC disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
F4 The price reported herein is a weighted average price. These shares were sold on the open market in multiple transactions at prices ranging from $0.90 to $0.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnote (4) to this Form 4.